Invokana & Invokamet: An overview

Watch this video to learn the who, what, when, and where of SGLT2 inhibitors; Invokana & Invokamet. With any medical drug or device it is always better to know too much than be left in the dark without any information.

In 2013 a new type of drug sodium-glucose cotransport or two inhibitors also known as sglt2 or canna cliff losen was released into the market to treat type 2 diabetes in adults in the first quarter of 2015 jansen’s profits from invokana were over 270 million in sales over 450,000 prescriptions of invokana are filled every three months in the united states both

Invokana and in vakama are made by janssen pharmaceuticals a johnson & johnson company in healthy people the liver produces glucose during fasting to maintain normal levels of cell energy production after people eat the pancreas releases insulin insulin is the hormone responsible for glucose absorption once insulin is released the liver should turn down or

Turn off its glucose production but in people with type 2 diabetes the liver fails to sense insulin and continues to make glucose invokana and in vakama are given in the form of a pill and work by preventing glucose absorption into the blood as a result more glucose is excreted in the urine lowering blood glucose levels and adults with type 2 diabetes in may 2015

The fda issued a safety warning for all sglt2 inhibitors including invokana and inva kamut after receiving reports of patients who developed diabetic ketoacidosis on december 4th 2015 the fda revised the label on invokana to include ketoacidosis after a growing number of patients were hospitalized as of may 2017 the fda has updated a warning after trial results

Found an increased risk of leg in foot amputations in patients taking the diabetic medication invokana or in the kamut amputations of the toe and middle foot were more common however amputations involving the leg below and above the knee also occurred some patients had more than one amputation some involving both limbs as scary as this sounds do not stop taking

Your diabetic medications without first talking to your healthcare professional doing so may lead to uncontrolled blood sugar levels that can be harmful traditional type 2 diabetes medications work to stop the glucose produced by the liver invokana doesn’t stop the production just the reabsorption of glucose into the bloodstream while this may sound like a good

Idea the problem is invokana and inva kamut are associated with amputations above and below the knee kidney failure diabetic ketoacidosis and myocardial infarction commonly known as a heart attack which includes the irreversible death of cells within the heart after experiencing life-threatening side effects many patients have sought compensation from the drug

Manufacturer janssen pharmaceuticals if you or a loved one took invokana or inva kamut you may have experienced any of the following life-threatening complications diabetic ketoacidosis kidney failure dialysis coma hospitalization amputation or even death the fda said patients should stop taking their sglt2 inhibitors and seek medical attention immediately if they

Have any symptoms of ketoacidosis symptoms include nausea vomiting abdominal pain tiredness and trouble breathing contact parascope group today so we can get you the help you need to seek financial compensation periscope group making sure consumers don’t become collateral damage

Transcribed from video
Invokana & Invokamet: An overview By Periscope Group